Cancer/Tumor Profiling Market Growth Report 2022-2027

1
Global Cancer/Tumor Profiling Market Research and
Forecast Report 2022-2027




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Cancer/Tumor Profiling Market Research
Report According to the latest report by IMARC
Group, titled Cancer/Tumor Profiling Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2022-2027 the global
cancer/tumor profiling market reached a strong
growth in 2021.  Cancer/tumor profiling, also
called biomarker testing, represents a laboratory
test or procedure that is used for identifying
specific proteins, gene mutations, and other
biomarkers in a tumor tissue sample. It assists
in therapeutic decision-making, routine
diagnostics, and developing customized treatment
therapies and plans for patients based on the
severity of their diseases and genomic build-up.
Consequently, cancer/tumor profiling finds
wide-ranging applications in research,
prognostics, the discovery of biomarkers, the
development of screening and diagnostic
techniques, etc. Request Free Sample Report
https//www.imarcgroup.com/cancer-tumor-profiling-
market/requestsample
4
Report Description and Highlights
Report Description

Global Cancer/Tumor Profiling Market Trends
The growing number of clinical trials and the
increasing adoption of immunoassay techniques are
among the primary factors driving the
cancer/tumor profiling market. Moreover, the
launch of various favorable policies by
government bodies across countries for
introducing numerous innovative techniques to
reduce the time taken for the detection and
identification of tumors is further catalyzing
the market growth. In line with this, several
technological advancements in molecular biology
techniques, such as next-generation sequencing
(NGS), are augmenting the utilization of
cancer/tumor profiling, which, in turn, is acting
as another significant growth-inducing factor.
Additionally, the elevating consumer inclination
towards personalized medicines is also positively
influencing the global market. Besides this, the
inflating investments by pharmaceutical and
biotechnology companies in RD activities for
developing new drug designing techniques and
novel therapies are anticipated to fuel the
cancer/tumor profiling market over the forecasted
period. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2022-2027).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Cancer Type
Breast Cancer Lung Cancer Col
orectal Cancer Prostate Cancer
Melanoma Cancer Others Breakup by Tech
nology Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC) In-Situ Hy
bridization (ISH) Microarray O
thers Breakup by Technique Genomics

6
Report Description and Highlights
Report Description
Proteomics Epigenetics
Metabolomics Breakup by Application
Personalized Medicine Diagnostics
Biomarker Discovery Prognostics
Others Breakup by Region North
America United States
Canada Asia Pacific
China Japan
India South Korea

7
Report Description and Highlights
Report Description
Australia Indo
nesia Others Europe
Germany France
United Kingdom
Italy Spain
Russia Others
Latin America Brazil
Mexico Others
Middle East and Africa Note We are updati
ng our reports, If you want latest primary and
secondary data (2022-2027) with Cost Module,
Business Strategy, Distribution Channel, etc.
Click request free sample report.

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Becton Dickinson and Company Caris Life Sciences E
  xact Sciences Corporation F. Hoffmann-La Roche Ltd
  Hologic Inc. HTG Molecular Diagnostics
  Inc. Illumina Inc. Laboratory Corporation of Ameri
  ca Holdings NeoGenomics Laboratories Qiagen N.V. S
  iemens AG Sysmex Corporation.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/cancer-tumor-profiling-
  market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us